140 related articles for article (PubMed ID: 33219753)
21. Xeroderma pigmentosum and molecular cloning of DNA repair genes.
Boulikas T
Anticancer Res; 1996; 16(2):693-708. PubMed ID: 8687116
[TBL] [Abstract][Full Text] [Related]
22. Novel XPG (ERCC5) mutations affect DNA repair and cell survival after ultraviolet but not oxidative stress.
Soltys DT; Rocha CR; Lerner LK; de Souza TA; Munford V; Cabral F; Nardo T; Stefanini M; Sarasin A; Cabral-Neto JB; Menck CF
Hum Mutat; 2013 Mar; 34(3):481-9. PubMed ID: 23255472
[TBL] [Abstract][Full Text] [Related]
23. Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients.
Emmert S; Slor H; Busch DB; Batko S; Albert RB; Coleman D; Khan SG; Abu-Libdeh B; DiGiovanna JJ; Cunningham BB; Lee MM; Crollick J; Inui H; Ueda T; Hedayati M; Grossman L; Shahlavi T; Cleaver JE; Kraemer KH
J Invest Dermatol; 2002 Jun; 118(6):972-82. PubMed ID: 12060391
[TBL] [Abstract][Full Text] [Related]
24. Expression of XPG protein in human normal and tumor tissues.
Aracil M; Dauffenbach LM; Diez MM; Richeh R; Moneo V; Leal JF; Fernández LF; Kerfoot CA; Galmarini CM
Int J Clin Exp Pathol; 2013; 6(2):199-211. PubMed ID: 23330005
[TBL] [Abstract][Full Text] [Related]
25. Cerebro-oculo-facio-skeletal syndrome caused by the homozygous pathogenic variant Gly47Arg in ERCC2.
Reunert J; van den Heuvel A; Rust S; Marquardt T
Am J Med Genet A; 2021 Mar; 185(3):930-936. PubMed ID: 33369099
[TBL] [Abstract][Full Text] [Related]
26. The Cerebro-oculo-facio-skeletal Syndrome Point Mutation F231L in the ERCC1 DNA Repair Protein Causes Dissociation of the ERCC1-XPF Complex.
Faridounnia M; Wienk H; Kovačič L; Folkers GE; Jaspers NG; Kaptein R; Hoeijmakers JH; Boelens R
J Biol Chem; 2015 Aug; 290(33):20541-55. PubMed ID: 26085086
[TBL] [Abstract][Full Text] [Related]
27. Complementation of transformed fibroblasts from patients with combined xeroderma pigmentosum-Cockayne syndrome.
Ellison AR; Nouspikel T; Jaspers NG; Clarkson SG; Gruenert DC
Exp Cell Res; 1998 Aug; 243(1):22-8. PubMed ID: 9716445
[TBL] [Abstract][Full Text] [Related]
28. Cell-autonomous progeroid changes in conditional mouse models for repair endonuclease XPG deficiency.
Barnhoorn S; Uittenboogaard LM; Jaarsma D; Vermeij WP; Tresini M; Weymaere M; Menoni H; Brandt RM; de Waard MC; Botter SM; Sarker AH; Jaspers NG; van der Horst GT; Cooper PK; Hoeijmakers JH; van der Pluijm I
PLoS Genet; 2014 Oct; 10(10):e1004686. PubMed ID: 25299392
[TBL] [Abstract][Full Text] [Related]
29. Irofulven cytotoxicity depends on transcription-coupled nucleotide excision repair and is correlated with XPG expression in solid tumor cells.
Koeppel F; Poindessous V; Lazar V; Raymond E; Sarasin A; Larsen AK
Clin Cancer Res; 2004 Aug; 10(16):5604-13. PubMed ID: 15328203
[TBL] [Abstract][Full Text] [Related]
30. Characterisation of a novel missense mutation in the
Stehnach WC; Cantor A; Bongiorno M
BMJ Case Rep; 2023 Oct; 16(10):. PubMed ID: 37848274
[TBL] [Abstract][Full Text] [Related]
31. ERCC6 founder mutation identified in Finnish patients with COFS syndrome.
Jaakkola E; Mustonen A; Olsen P; Miettinen S; Savuoja T; Raams A; Jaspers NG; Shao H; Wu BL; Ignatius J
Clin Genet; 2010 Dec; 78(6):541-7. PubMed ID: 20456449
[TBL] [Abstract][Full Text] [Related]
32. Recognition of RNA polymerase II and transcription bubbles by XPG, CSB, and TFIIH: insights for transcription-coupled repair and Cockayne Syndrome.
Sarker AH; Tsutakawa SE; Kostek S; Ng C; Shin DS; Peris M; Campeau E; Tainer JA; Nogales E; Cooper PK
Mol Cell; 2005 Oct; 20(2):187-98. PubMed ID: 16246722
[TBL] [Abstract][Full Text] [Related]
33. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.
Lu B; Li J; Gao Q; Yu W; Yang Q; Li X
Gene; 2014 May; 542(1):64-8. PubMed ID: 24582975
[TBL] [Abstract][Full Text] [Related]
34. Defective transcription-coupled repair of oxidative base damage in Cockayne syndrome patients from XP group G.
Cooper PK; Nouspikel T; Clarkson SG; Leadon SA
Science; 1997 Feb; 275(5302):990-3. PubMed ID: 9020084
[TBL] [Abstract][Full Text] [Related]
35. Genetic polymorphisms of the XPG and XPD nucleotide excision repair genes in sarcoma patients.
Le Morvan V; Longy M; Bonaïti-Pellié C; Bui B; Houédé N; Coindre JM; Robert J; Pourquier P
Int J Cancer; 2006 Oct; 119(7):1732-5. PubMed ID: 16646069
[TBL] [Abstract][Full Text] [Related]
36. Xeroderma pigmentosum complementation group G patient with a novel homozygous missense mutation and no neurological abnormalities.
Moriwaki S; Takigawa M; Igarashi N; Nagai Y; Amano H; Ishikawa O; Khan SG; Kraemer KH
Exp Dermatol; 2012 Apr; 21(4):304-7. PubMed ID: 22417308
[TBL] [Abstract][Full Text] [Related]
37. Xeroderma pigmentosum/cockayne syndrome complex: first neuropathological study and review of eight other cases.
Lindenbaum Y; Dickson D; Rosenbaum P; Kraemer K; Robbins I; Rapin I
Eur J Paediatr Neurol; 2001; 5(6):225-42. PubMed ID: 11764181
[TBL] [Abstract][Full Text] [Related]
38. Functional and molecular genetic analyses of nine newly identified XPD-deficient patients reveal a novel mutation resulting in TTD as well as in XP/CS complex phenotypes.
Schäfer A; Gratchev A; Seebode C; Hofmann L; Schubert S; Laspe P; Apel A; Ohlenbusch A; Tzvetkov M; Weishaupt C; Oji V; Schön MP; Emmert S
Exp Dermatol; 2013 Jul; 22(7):486-9. PubMed ID: 23800062
[TBL] [Abstract][Full Text] [Related]
39. Xeroderma pigmentosum--Cockayne syndrome complex: a further case.
Hamel BC; Raams A; Schuitema-Dijkstra AR; Simons P; van der Burgt I; Jaspers NG; Kleijer WJ
J Med Genet; 1996 Jul; 33(7):607-10. PubMed ID: 8818951
[TBL] [Abstract][Full Text] [Related]
40. Mutations that disable the DNA repair gene XPG in a xeroderma pigmentosum group G patient.
Nouspikel T; Clarkson SG
Hum Mol Genet; 1994 Jun; 3(6):963-7. PubMed ID: 7951246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
